Azenta (NASDAQ:AZTA – Get Free Report) is set to issue its quarterly earnings data after the market closes on Tuesday, August 6th. Analysts expect the company to announce earnings of $0.07 per share for the quarter. Azenta has set its FY24 guidance at $0.27-0.37 EPS.Parties interested in participating in the company’s conference call can do so using this link.
Azenta (NASDAQ:AZTA – Get Free Report) last posted its quarterly earnings data on Wednesday, May 8th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Azenta had a positive return on equity of 0.81% and a negative net margin of 23.12%. The business had revenue of $159.13 million during the quarter, compared to analysts’ expectations of $159.89 million. During the same period in the previous year, the business earned ($0.06) earnings per share. The business’s revenue was up 7.2% compared to the same quarter last year. On average, analysts expect Azenta to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Azenta Stock Up 1.6 %
Shares of AZTA traded up $0.99 during trading hours on Tuesday, hitting $61.64. 112,825 shares of the stock were exchanged, compared to its average volume of 461,037. Azenta has a 12-month low of $44.00 and a 12-month high of $69.16. The stock’s 50-day moving average price is $53.75 and its two-hundred day moving average price is $57.77.
Wall Street Analyst Weigh In
View Our Latest Analysis on Azenta
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
See Also
- Five stocks we like better than Azenta
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- What is the Dow Jones Industrial Average (DJIA)?
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- Top Biotech Stocks: Exploring Innovation Opportunities
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.